Quick Answer
Ocugen, Inc. reported Stockholders Equity of -$12.17 million for fiscal year 2025.
Ocugen, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$12.17M | -141.1% |
| 2024 | $29.63M | -27.0% |
| 2023 | $40.56M | -18.5% |
| 2023 | $49.80M | -15.9% |
| 2023 | $59.24M | -8.7% |
| 2023 | $64.90M | -12.3% |
| 2022 | $73.98M | -13.7% |
| 2022 | $85.69M | -19.5% |
| 2022 | $106.48M | -15.2% |
| 2022 | $125.52M | +37.6% |
| 2021 | $91.20M | +323.2% |
| 2020 | $21.55M | +95.6% |
| 2019 | $11.02M | +186.7% |
| 2018 | -$12.71M | -386.6% |
| 2017 | $4.43M | -67.3% |
| 2016 | $13.57M | -51.9% |
| 2015 | $28.20M | -48.0% |
| 2014 | $54.21M | +171.7% |
| 2013 | -$75.55M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.53M | -91.3% | +15.8% |
| June 30, 2025 | $3.05M | -82.0% | -80.8% |
| March 31, 2025 | $15.91M | -47.4% | -46.3% |
| December 31, 2024 | $29.63M | -27.0% | -27.1% |
| September 30, 2024 | $40.63M | -18.4% | +140.0% |
| June 30, 2024 | $16.93M | -71.4% | -44.1% |
| March 31, 2024 | $30.26M | -53.4% | -25.4% |
| December 31, 2023 | $40.56M | -45.2% | -18.5% |
- Ocugen, Inc. showed a decrease of -141.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2013–2025 period, Ocugen, Inc.’s stockholders equity has grown by 83.9% (from -$75.55 million to -$12.17 million).
- The most recent figure is from Ocugen, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: